Precipio urges immediate shareholder votes to avoid meeting adjournment
Precipio is urging shareholders to vote by June 14, 2026, to ensure a quorum for its Annual Meeting on June 15, 2026. With only 42% of shares voted so far, the company risks adjournment and additional costs if the 50% threshold is not met. Management requests all shareholders to submit instructions regardless of their vote direction.
*this image is generated using AI for illustrative purposes only.
Precipio is requesting shareholders to instruct their brokers to vote their shares immediately to avoid the high additional costs associated with adjourning its Annual Shareholders Meeting. The company needs a minimum of 50% of shares to be voted to establish a quorum, but only approximately 42% of shares have been voted at the time of this press release. The Annual Meeting is scheduled for June 15, 2026, at 10 a.m. Eastern Time.
Votes must be received by 11:59 p.m., Eastern Time, on June 14, 2026, to be counted at the meeting. Management emphasized that whether shareholders intend to vote for or against the proposals, submitting voting instructions is critical to ensuring the shares count toward the quorum. If the company does not receive sufficient votes, it may need to adjourn and reconvene the meeting, resulting in avoidable expenses.
Meeting Details and Requirements
The following table outlines the key dates and voting thresholds for the upcoming meeting:
| Event | Date/Time | Requirement |
|---|---|---|
| Voting Deadline | June 14, 2026, 11:59 p.m. ET | Votes must be received by this time |
| Annual Meeting | June 15, 2026, 10 a.m. ET | Quorum required to proceed |
| Quorum Threshold | N/A | Minimum 50% of shares voted |
| Current Participation | N/A | Approximately 42% of shares voted |
Precipio operates as a healthcare biotechnology company focused on cancer diagnostics. The company develops diagnostic products and services to address cancer misdiagnoses, aiming to improve accuracy and patient outcomes while reducing healthcare expenses.
What specific proposals are on the agenda that require shareholder approval?
How might the potential adjournment costs impact Precipio's operational budget?
What strategies is management employing to engage the remaining 8% of shareholders needed for a quorum?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
